Wynzora 50/500 (calcipotriol + betamethasone dipropionate)
Calcipotriol 0.005% + betamethasone (as dipropionate) 0.05% cream, 60 g · APPLICATION · PBS code 15212P
RESTRICTEDWhat it costs
AU$47.66 PBS-determined price per 2 units
Most patients pay only the standard PBS co-payment, not the full price above — up to AU$25.00 per script (general) or AU$7.70 (concession/Safety Net) in 2026. The figure above is what the PBS pays the pharmacy; the Australian Government subsidises the rest. Always confirm the current amount with your pharmacist.
- • First listed on the PBS: 2026-02-01.
- • Repeats: 1.
- • PBS program: GE.
Eligibility criteria for subsidised access
The following is the government's own wording from the PBS Schedule, shown unchanged.
Listing of Pharmaceutical Benefits (NHL) - Schedule 4 part 1
Chronic stable plaque type psoriasis vulgaris
The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient; AND
The condition must be inadequately controlled by potent topical corticosteroid monotherapy.
Sponsor: ACTOR PHARMACEUTICALS PTY LTD ABN 69 151 192 602
Not medical advice. Voxsanity republishes public PBS data in plain English. PBS listing status and criteria can change; always confirm current subsidised availability with your doctor or pharmacist.
Source: Pharmaceutical Benefits Scheme (PBS), © Commonwealth of Australia. Data used and redistributed under permission; not modified from its original wording where displayed verbatim.